Question
The monoclonal antibody approved for use in Cl.difficile infections is-
| A. |
Rituximab |
| B. |
Denosumab |
| C. |
Durvalumab |
| D. |
Bezlotoxumab |
Show Answer
|
Correct Answer � D Explanation |
 |
Ans.D. Bezlotoxumab is a monoclonal antibody neutralizes the toxin B of Cl.difficle after binding it.
It is indicated in high-risk patients for reducing recurrence.